JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayall, F
Right arrow Articles by Shanks, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayall, F
Right arrow Articles by Shanks, J
Journal of Clinical Pathology 2003;56:728-730
© 2003 BMJ Publishing Group Ltd. & Association of Clinical Pathologists


ORIGINAL ARTICLE

The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols

F Mayall1, K Barratt1, J Shanks2

1 Department of Pathology, Waikato Hospital, Hamilton, New Zealand
2 Department of Pathology, The Christie Hospital, Didsbury, Manchester M20 4BX, UK

Correspondence to:
Dr F G Mayall, Department of Pathology, Waikato Hospital, Private Bag 3200, Hamilton, New Zealand;
mayallf{at}hwl.co.nz Aims: To detect Simian virus 40 (SV40) DNA in mesotheliomas from New Zealand and from England using novel real time FRET probe polymerase chain reaction (PCR) protocols.

Methods: Twenty four mesotheliomas from New Zealand (Central North Island) and 32 mesotheliomas from England (Greater Manchester region) were examined. Two real time FRET probe PCR protocols were optimised and their analytical sensitivity compared using dilutions of SV40 DNA. A conventional SV40 large tumour antigen protocol with detection by probe hybridisation and chemiluminescent Southern blotting was also optimised.

Results: Both real time PCR protocols had the same analytical sensitivity, detecting down to 10-6 pg of SV40 DNA for each reaction, approximately one SV40 copy. All of the 56 mesothelioma samples contained amplifiable ß globin DNA, but none contained amplifiable SV40 DNA with the conventional large T antigen PCR–Southern blotting protocol, or the two real time FRET probe PCR protocols. The positive and negative controls gave the expected results. There was no evidence of inhibition.

Conclusions: There is abundant evidence in the literature for the presence of SV40 in mesotheliomas. However, this study found no evidence of SV40 in mesotheliomas from England and New Zealand. The extensive use of SV40 contaminated polio vaccine in New Zealand does not seem to have resulted in SV40 associated mesotheliomas.


Keywords: mesothelioma; Simian virus 40; oncogenesis; polymerase chain reaction; virus

Abbreviations: CK, cytokeratin; PCR, polymerase chain reaction; SV40, Simian virus 40




This article has been cited by other articles:


Home page
JCOHome page
D. L. Poulin and J. A. DeCaprio
Is There a Role for SV40 in Human Cancer?
J. Clin. Oncol., September 10, 2006; 24(26): 4356 - 4365.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.